medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2022-2-7-10medalphabet-2521Research ArticleСтатьиПерспективы применения пробиотиков при лечении периимплантита. Обзор литературыPerspectives for the use of probiotics in the treatment of peri-implantitis. Literature reviewehttps://orcid.org/0000-0001-9995-3749ДжафаровЭ. М.DzhafarovM.

Джафаров Эльнур Матлаб оглы, заочный аспирант кафедры стоматологии общей практики и детской стоматологии

Ставрополь

Dzhafarov Elnur Matlab ogly, Postgraduate Student, Department of General Practice and Pediatric Dentistry

Stavropol

elnur985@mail.ruhttps://orcid.org/0000-0002-1711-1415ЭдишерашвилиУ. Б.EdisherashviliU. B.

Эдишерашвили Ушанги Бесикович, заочный аспирант кафедры стоматологии общей практики и детской стоматологии

Ставрополь

Edisherashvili Ushangi Besikovich, Postgraduate of the Department of general and pediatric dentistry

Stavropol

ushangi.master@mail.ruhttps://orcid.org/0000-0002-6352-6750ДолгалевА. А.DolgalevA. A.

Долгалев Александр Александрович, доктор медицинских наук, доцент, начальник центра инноваций и трансфера технологий, профессор кафедры стоматологии общей практики и детской стоматологии, профессор кафедры клинической стоматологии с курсом

Ставрополь

Dolgalev Alexander Alexandrovich, PhD, MD, Head of the Center for Innovation and Technology Transfer, Professor of the Department of General Practice Dentistry and Pediatric Dentistry, Professor of the Department of Clinical Dentistry with a course of OS and MFS

Stavropol

dolgalev@dolgalev.proГаражаС. Н.GarazaS. N.

Гаража Сергей Николаевич, доктор медицинских наук, профессор, заведующий кафедрой пропедевтики стоматологических заболеваний

Ставрополь

Garaza Sergey Nikolaevich, MD, Professor, Head of the Department of Propaedeutics of Dental Diseases

Stavropol

https://orcid.org/0000-0003-2328-6948ШульгаГ. С.ShulgaG. S.

Шульга Галина Сергеевна, студентка стоматологического факультета

Ставрополь

Shulga Galina Sergeevna, student of the Faculty of Dentistry

Stavropol

g.dolgopolowa2015@yandex.ruhttps://orcid.org/0000-0001-8980-6235ДымниковА. Б.DymnikovA. B.

Дымников Александр Борисович, к.м.н., доцент кафедры челюстно-лицевой хирургии и хирургической стоматологии

SPIN-код: 7254-4306

AuthorID: 793591

Москва

Dymnikov Alexander Borisovich, Lecturer of the department, Oral and Maxillofacial surgery department

Moscow

dymnikov_ab@pfur.ruФГБОУ ВО «Ставропольский государственный медицинский университет» Министерства здравоохранения РФРоссияStavropol State Medical UniversityRussian FederationРоссийский университет Дружбы народовРоссияThe Peoples’ Friendship University of RussiaRussian Federation20220704202202Стоматология (1)710Copyright © Джафаров Э.М., Эдишерашвили У.Б., Долгалев А.А., Гаража С.Н., Шульга Г.С., Дымников А.Б., 20222022Джафаров Э.М., Эдишерашвили У.Б., Долгалев А.А., Гаража С.Н., Шульга Г.С., Дымников А.Б.Dzhafarov M., Edisherashvili U.B., Dolgalev A.A., Garaza S.N., Shulga G.S., Dymnikov A.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/2521

Применение дентальных имплантатов для лечения при частичной и полной адентии с каждым годом увеличивается. Вслед за этим, несмотря на улучшение качества оказания стоматологических услуг, увеличивается и процент осложнений. Одним из наиболее частых осложнений при имплантологическом лечении – периимплантит. Микроорганизмы вызывающие данный процесс находятся в биопленка на поверхности имплантата, что осложняет лечение и снижает эффективность противомикробных препаратов. Один из принципов современной медицины – профилактика, в связи с этим открываются новые перспективы для применения пробиотиков.

The use of dental implants for the treatment of partial and complete adentia is increasing every year. Following this, despite the improvement in the quality of dental services, the percentage of complications also increases. One of the most common complications in implant treatment is peri-implantitis. The microorganisms causing this process are in the biofilm on the surface of the implant, which complicates the treatment and reduces the effectiveness of antimicrobials. One of the principles of modern medicine is prevention, which opens up new prospects for the use of probiotics.

периимплантитпробиотикS. salivariusантибактериальная терапиямикробиоценозperi-implantitisprobioticS. salivariusantibiotic therapymicrobiocenosisReferencesГригорьян А.С. Основные направления развития фундаментальных исследований в стоматологии // Стоматология сегодня и завтра: материалы Всерос. науч.-практ. конф. М.: ГЭОТАР-Медиа, 2005. С. 82–89.Grigoryan A.S. The main directions of development of fundamental research in dentistry // Stomatology today and tomorrow: materials of Vseros. scientificpractical. conf. M.: GEOTAR-Media, 2005. P. 82–89.Грудянов А.И. Заболевания пародонта // М.:Медицинское информационное агентство, 2009. 331 с.Grudyanov A.I. Periodontal diseases // M.: Medical information agency, 2009. 331 p.Грудянов А.И., Овчинникова В.В. Частота выявления различных представителей пародонтопатогенной микрофлоры при пародонтите разной степени тяжести // Стоматология. 2009. № 3. С. 34–37.Grudyanov A.I., Ovchinnikova V.V. The frequency of detection of various representatives of periodontopathogenic microflora in periodontitis of varying severity // Dentistry. 2009. No. 3. S. 34–37.Джафаров Э.М., Долгалев А.А., Матвиенко Э.Р., Матюта М.А. Перспективы применения пробиотиков при имплантологическом лечении// Медицинский алфавит. 2020.- №35 (449). – С.10-12.Dzhafarov E.M., Dolgalev A.A., Matvienko E.R., Matyuta M.A. Prospects for the use of probiotics in implant treatment // Medical Alphabet. 2020. No. 35 (449). – P. 10–12.Becker DE. Antimicrobial drugs. AnesthProg. 2013;60:111–22.Becker DE. Antimicrobial drugs. AnesthProg. 2013;60:111–22.Becker DE. Drug allergies and implications for dental practice. AnesthProg. 2013;60:188–97.Becker DE. Drug allergies and implications for dental practice. AnesthProg. 2013;60:188–97.Bennadi D. Self-medication: A current challenge. J Basic Clin Pharm. 2013;5:19–23.Bennadi D. Self-medication: A current challenge. J Basic Clin Pharm. 2013;5:19–23.Burton JP, Chilcott CN, Wescombe PA, Tagg JR. Extended safety data for the oral cavity probiotic Streptococcus salivarius K12. Probiotics Antimicrob Proteins. 2010;2(3):135–44.Burton JP, Chilcott CN, Wescombe PA, Tagg JR. Extended safety data for the oral cavity probiotic Streptococcus salivarius K12. Probiotics Antimicrob Proteins. 2010;2(3):135–44.Burton JP, Cowley S, Simon RR, McKinney J, Wescombe PA, Tagg JR. Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2011;49(9):2356–64.Burton JP, Cowley S, Simon RR, McKinney J, Wescombe PA, Tagg JR. Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc. 2011;49(9):2356–64.Burton JP, Drummond BK, Chilcott CN, Tagg JR, Thomson WM, Hale JD, et al. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebocontrolled trial. J Med Microbiol. 2013;62(Pt 6):875–84.Burton JP, Drummond BK, Chilcott CN, Tagg JR, Thomson WM, Hale JD, et al. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebocontrolled trial. J Med Microbiol. 2013;62(Pt 6):875–84.Burton JP, Wescombe PA, Macklaim JM, Chai MH, Macdonald K, Hale JD, et al. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics. PLoS ONE. 2013;8(6):e65991.Burton JP, Wescombe PA, Macklaim JM, Chai MH, Macdonald K, Hale JD, et al. Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics. PLoS ONE. 2013;8(6):e65991.Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol. 2006;72(4):3050–3.Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol. 2006;72(4):3050–3.Burton, J., Wescombe, P., Cadieux, P., Tagg, J. Beneficial microbes for the oral cavity: Time to harness the oral streptococci? Benef. Microbes 2011, 2, 93–101. [CrossRef]Burton, J., Wescombe, P., Cadieux, P., Tagg, J. Beneficial microbes for the oral cavity: Time to harness the oral streptococci? Benef. Microbes 2011, 2, 93–101. [CrossRef]Catalya S., Komal B., Tulpule S., Raoof N., Sen S. Isolated streptococcus intermedius pulmonary nodules. IDCases 2017, 8, 48–49. [CrossRef]Catalya S., Komal B., Tulpule S., Raoof N., Sen S. Isolated streptococcus intermedius pulmonary nodules. IDCases 2017, 8, 48–49. [CrossRef]Crittenden RG, Martinez NR, Playne MJ. Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int J Food Microbiol. 2003;80(3):217–22.Crittenden RG, Martinez NR, Playne MJ. Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int J Food Microbiol. 2003;80(3):217–22.De La Garza-Ramos M.A., Galán-Wong L.J., Ca_esse R.G., González-Salazar F., Pereyra-Alférez B. Detection of porphyromonas gingivalis and Streptococcus intermedius in chronic periodontitis patients by multiplex PCR. Gene 2008, 21, 163–167. Pathogens 2020, 9, 1069 13 of 15.De La Garza-Ramos M.A., Galán-Wong L.J., Ca_esse R.G., González-Salazar F., Pereyra-Alférez B. Detection of porphyromonas gingivalis and Streptococcus intermedius in chronic periodontitis patients by multiplex PCR. Gene 2008, 21, 163–167. Pathogens 2020, 9, 1069 13 of 15.Di Pierro F, Adami T, Rapacioli G, Giardini N, Streitberger C. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opin Biol Ther. 2013;13(3):339–43.Di Pierro F, Adami T, Rapacioli G, Giardini N, Streitberger C. Clinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adults. Expert Opin Biol Ther. 2013;13(3):339–43.Di Pierro F, Donato G, Fomia F, Adami T, Careddu D, Cassandro C, et al. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media. Int J Gen Med. 2012;5:991–7.Di Pierro F, Donato G, Fomia F, Adami T, Careddu D, Cassandro C, et al. Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media. Int J Gen Med. 2012;5:991–7.Elemek E., Almas K. Peri-implantitis: Etiology, diagnosis and treatment: An update. N. Y. State Dent. J. 2014, 80, 26–32Elemek E., Almas K. Peri-implantitis: Etiology, diagnosis and treatment: An update. N. Y. State Dent. J. 2014, 80, 26–32Griggs J.A. Dental implants. Dent. Clin. N. Am. 2017, 61, 857–871. [CrossRef]Griggs J.A. Dental implants. Dent. Clin. N. Am. 2017, 61, 857–871. [CrossRef]Guglielmotti, M.B.; Olmedo, D.G.; Cabrini, R.L. Research on implants and osseointegration. Periodontol. 2000 2019, 79, 178–189. [CrossRef]Guglielmotti, M.B.; Olmedo, D.G.; Cabrini, R.L. Research on implants and osseointegration. Periodontol. 2000 2019, 79, 178–189. [CrossRef]Heller D., Helmerhorst E.J., Gower A.C., Siqueira W.L., Paster B.J., Oppenheim F.G. Microbial diversity in the early in vivo-formed dental biofilm. Appl. Environ. Microbiol. 2016, 82, 1881–1888. [CrossRef]Heller D., Helmerhorst E.J., Gower A.C., Siqueira W.L., Paster B.J., Oppenheim F.G. Microbial diversity in the early in vivo-formed dental biofilm. Appl. Environ. Microbiol. 2016, 82, 1881–1888. [CrossRef]Horz HP, Meinelt A, Houben B, Conrads G. Distribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real-time quantitative polymerase chain reaction. Oral Microbiol Immunol. 2007;22(2):126–30.Horz HP, Meinelt A, Houben B, Conrads G. Distribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real-time quantitative polymerase chain reaction. Oral Microbiol Immunol. 2007;22(2):126–30.Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl Environ Microbiol. 2007;73(4):1107–13. 21.Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl Environ Microbiol. 2007;73(4):1107–13. 21.Kaci G, Lakhdari O, Dore J, Ehrlich SD, Renault P, Blottiere HM, et al. Inhibition of the NF-kappaB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius. Appl Environ Microbiol. 2011;77(13):4681–4.Kaci G, Lakhdari O, Dore J, Ehrlich SD, Renault P, Blottiere HM, et al. Inhibition of the NF-kappaB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius. Appl Environ Microbiol. 2011;77(13):4681–4.Kaga, A.; Higo, R.; Yoshikawa, H.; Yokoi, N.; Haruyama, T.; Komatsu, H.; Yabe A.; Kusunoki T.; Ikeda K. A case of multiple empyema caused by Streptococcus intermedius. Auris Nasus Larynx 2017, 44, 745–748. [CrossRef]Kaga, A.; Higo, R.; Yoshikawa, H.; Yokoi, N.; Haruyama, T.; Komatsu, H.; Yabe A.; Kusunoki T.; Ikeda K. A case of multiple empyema caused by Streptococcus intermedius. Auris Nasus Larynx 2017, 44, 745–748. [CrossRef]Kanwar I.; Sah, A.K.; Suresh P.K. Biofilm-mediated antibiotic-resistant oral bacterial infections: Mechanism and combat strategies. Curr. Pharm. Des. 2017, 23, 2084–2095. [CrossRef]Kanwar I.; Sah, A.K.; Suresh P.K. Biofilm-mediated antibiotic-resistant oral bacterial infections: Mechanism and combat strategies. Curr. Pharm. Des. 2017, 23, 2084–2095. [CrossRef]Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer R-JM, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol. 2010;298(6):G851–9.Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer R-JM, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol. 2010;298(6):G851–9.Kreth, J.; Merritt, J.; Qi, F. Bacterial and host interactions of oral streptococci. DNA Cell Biol. 2009, 28, 397–403. [CrossRef]Kreth, J.; Merritt, J.; Qi, F. Bacterial and host interactions of oral streptococci. DNA Cell Biol. 2009, 28, 397–403. [CrossRef]Laleman I, Teughels W. Probiotics in the dental practice: a review. Quintessence Int. 2015;46:255–64.Laleman I, Teughels W. Probiotics in the dental practice: a review. Quintessence Int. 2015;46:255–64.Livingston L.V.; Perez-Colon E. Streptococcus intermedius bacteremia and liver abscess following a routine dental cleaning. Case Rep. Infect. Dis. 2014, 2014, 1–4. [CrossRef]Livingston L.V.; Perez-Colon E. Streptococcus intermedius bacteremia and liver abscess following a routine dental cleaning. Case Rep. Infect. Dis. 2014, 2014, 1–4. [CrossRef]Mahato, N.; Wu, X.; Wang, L. Management of peri-implantitis: A systematic review, 2010–2015. Springerplus 2016, 5, 105. [CrossRef]Mahato, N.; Wu, X.; Wang, L. Management of peri-implantitis: A systematic review, 2010–2015. Springerplus 2016, 5, 105. [CrossRef]Manning J, Dunne EM, Wescombe PA, Hale JDF, Mulholland EK, Tagg JR, et al. Investigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cells. BMC Microbiol. 2016;16(1):225.Manning J, Dunne EM, Wescombe PA, Hale JDF, Mulholland EK, Tagg JR, et al. Investigation of Streptococcus salivarius-mediated inhibition of pneumococcal adherence to pharyngeal epithelial cells. BMC Microbiol. 2016;16(1):225.Meurman JH, Stamatova I. Probiotics: contributions to oral health. Oral Dis. 2007;13:443–51.Meurman JH, Stamatova I. Probiotics: contributions to oral health. Oral Dis. 2007;13:443–51.Mishra A.K.; Fournier P.-E. The role of Streptococcus intermedius in brain abscess. Eur. J. Clin. Microbiol. Infect. Dis. 2013, 32, 477–483. [CrossRef]Mishra A.K.; Fournier P.-E. The role of Streptococcus intermedius in brain abscess. Eur. J. Clin. Microbiol. Infect. Dis. 2013, 32, 477–483. [CrossRef]Mitrakul K.; Asvanund Y.; Vongsavan, K. Prevalence of five biofilm-related oral streptococci species from plaque. J. Clin. Pediatr. Dent. 2011, 36, 161–166. [CrossRef]Mitrakul K.; Asvanund Y.; Vongsavan, K. Prevalence of five biofilm-related oral streptococci species from plaque. J. Clin. Pediatr. Dent. 2011, 36, 161–166. [CrossRef]Morishita T, Tamura N, Makino T, Kudo S. Production of menaquinones by lactic acid bacteria. J Dairy Sci. 1999;82(9):1897–903.Morishita T, Tamura N, Makino T, Kudo S. Production of menaquinones by lactic acid bacteria. J Dairy Sci. 1999;82(9):1897–903.Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med. 1998;9(3):248–66.Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med. 1998;9(3):248–66.Pita P.P.C., Rodrigues J.A., Ota-Tsuzuki C., Miato T.F., Zenobio E.G., Giro G., Figueiredo L.C., Gonçalves C., Gehrke S.A., Cassoni A. et al. Oral streptococci biofilm formation on di_erent implant surface topographies. Biomed Res. Int. 2015, 2015, 1–6. [CrossRef]Pita P.P.C., Rodrigues J.A., Ota-Tsuzuki C., Miato T.F., Zenobio E.G., Giro G., Figueiredo L.C., Gonçalves C., Gehrke S.A., Cassoni A. et al. Oral streptococci biofilm formation on di_erent implant surface topographies. Biomed Res. Int. 2015, 2015, 1–6. [CrossRef]Roslund MI, Puhakka R, Gronroos M, Nurminen N, Oikarinen S, Gazali AM, et al. Biodiversity intervention enhances immune regulation and healthassociated commensal microbiota among daycare children. Sci Adv. 2020;6(42):eaba2578.Roslund MI, Puhakka R, Gronroos M, Nurminen N, Oikarinen S, Gazali AM, et al. Biodiversity intervention enhances immune regulation and healthassociated commensal microbiota among daycare children. Sci Adv. 2020;6(42):eaba2578.Tanner A., Maiden M.F.J., Lee K., Shulman L.B., Weber H.P. Dental implant infections. Clin. Infect. Dis.Tanner A., Maiden M.F.J., Lee K., Shulman L.B., Weber H.P. Dental implant infections. Clin. Infect. Dis.Vacca C, Contu MP, Rossi C, Ferrando ML, Blus C, Szmukler-Moncler S, Scano A, Orrù G. In vitro Interactions between Streptococcus intermedius and Streptococcus salivarius K12 on a Titanium Cylindrical Surface. Pathogens. 2020 Dec 20;9(12):1069. doi: 10.3390/pathogens9121069. PMID: 33419248; PMCID: PMC7765831.]Vacca C, Contu MP, Rossi C, Ferrando ML, Blus C, Szmukler-Moncler S, Scano A, Orrù G. In vitro Interactions between Streptococcus intermedius and Streptococcus salivarius K12 on a Titanium Cylindrical Surface. Pathogens. 2020 Dec 20;9(12):1069. doi: 10.3390/pathogens9121069. PMID: 33419248; PMCID: PMC7765831.]Wescombe PA, Burton JP, Cadieux PA, Klesse NA, Hyink O, Heng NC, et al. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius. Antonie Van Leeuwenhoek. 2006;90(3):269–80.Wescombe PA, Burton JP, Cadieux PA, Klesse NA, Hyink O, Heng NC, et al. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius. Antonie Van Leeuwenhoek. 2006;90(3):269–80.Wescombe PA, Heng NC, Burton JP, Chilcott CN, Tagg JR. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol. 2009;4(7):819–35.Wescombe PA, Heng NC, Burton JP, Chilcott CN, Tagg JR. Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics. Future Microbiol. 2009;4(7):819–35.Zitzmann N.U., Berglundh T. Definition and prevalence of peri-implant diseases. J. Clin. Periodontol. 2008, 35, 286–291. [CrossRef]Zitzmann N.U., Berglundh T. Definition and prevalence of peri-implant diseases. J. Clin. Periodontol. 2008, 35, 286–291. [CrossRef]

The authors declare that there are no conflicts of interest present.